Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA
BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA
BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA
Submitted by
admin
on October 31, 2012 - 11:45am
Source:
Yahoo
News Tags:
Biocryst
BCX5191
hepatitis C
Headline:
BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA
Do Not Allow Advertisers to Use My Personal information
